Haemonetics Announces Promotion of Brian Concannon to CEO Effective ... ( Brad Nutter to Continue in ...)

Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009

Date:10/27/2008

Brad Nutter to Continue in Role of Chairman of the Board

BRAINTREE, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today that Brian Concannon will be promoted to the position of President and CEO effective in April 2009, succeeding Brad Nutter in this role. Brian will also join the Haemonetics Board of Directors at that time. Brad Nutter will continue as Chairman and CEO until April 2009 and thereafter will remain an employee of the Company as Executive Chairman of the Haemonetics Board of Directors.

Brian Concannon joined Haemonetics in September 2003 as President of the Patient Division following an eighteen year career with progressively responsible leadership roles with American Hospital Supply Corporation, Baxter Healthcare Corporation, Allegiance Healthcare, and Cardinal Health Products and Services. As President of our Patient Division, Mr. Concannon led the expansion of our selling organization in concert with our decision to take direct the OrthoPAT(R) orthopedic perioperative autotransfusion product line. In 2006, he was promoted to President of Global Markets where he led the transformation of our businesses in Asia, Japan and Europe. In 2007, Mr. Concannon's responsibilities were again expanded to encompass oversight of all of our geographic sales and marketing operations and established lines of business as our Chief Operating Officer. Mr. Concannon is a 1979 graduate of the U.S. Military Academy at West Point, with a B.S. degree in engineering.

Ron Gelbman, Lead Director of the Board of Directors said, "Brad has made significant contributions to the growth of the company and the creation of shareholder value over the past six years. The Board appreciates his continued leadership in the role of Executive Chairman where he will focus on corporate governance and supporting the implementation of Haemonetics' corporate vision. We are also delighted by the appointment of Brian Concannon as Preside
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. Haemonetics Appoints Executive Leadership of European Operations
4. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
5. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
6. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
7. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
8. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
9. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
10. Haemonetics Sets Date for First Quarter Fiscal Year 2009 Earnings Release and Conference Call - August 1, 2008
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness

Post Your Comments:

Haemonetics Announces Promotion of Brian Concannon to CEO Effective ...( Brad Nutter to Continue in ...),Health